MITF and neoplasm: One study based on immunostaining of tumour specimens (Granter et al, 2001) concluded that Mitf is a marker for CCS, but did not confirm expression of the Mitf-M isoform due to detection method employed and use of the D5 Mitf-antibody (Hemesath et al, 1998) that recognises all Mitf isoforms.